Sagimet Biosciences (SGMT) PT Raised to $35 at Citizens After MASH Drug Presentations
Tweet Send to a Friend
Citizens analyst Jonathan Wolleben raised the price target on Sagimet Biosciences Inc (NASDAQ: SGMT) to $35.00 (from $33.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
